X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
hematology (31) 31
tailored prophylaxis (31) 31
humans (29) 29
hemophilia (25) 25
prophylaxis (23) 23
children (18) 18
child (12) 12
male (11) 11
recombinant factor-viii (11) 11
hemophilia a - drug therapy (10) 10
hemophilia a - therapy (10) 10
treatment outcome (10) 10
arthropathy (9) 9
child, preschool (9) 9
haemophilia (9) 9
hemorrhage - prevention & control (9) 9
peripheral vascular disease (9) 9
quality of life (9) 9
adult (8) 8
factor viii - therapeutic use (8) 8
factor-viii (8) 8
inhibitor development (8) 8
on-demand (8) 8
pharmacokinetics (8) 8
prophylactic treatment (8) 8
quality-of-life (8) 8
adolescent (7) 7
factor viii (7) 7
factor viii - administration & dosage (7) 7
fc fusion protein (7) 7
hemophilia a - blood (7) 7
hemophilia a - complications (7) 7
on-demand treatment (7) 7
secondary prophylaxis (7) 7
drug administration schedule (6) 6
factor ix (6) 6
haemophilia a (6) 6
half-life (6) 6
hemophilia a - prevention & control (6) 6
infant (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
middle aged (6) 6
oncology (6) 6
population pharmacokinetics (6) 6
severity of illness index (6) 6
aged (5) 5
bleeding (5) 5
canadian hemophilia (5) 5
clinical medicine (5) 5
experience (5) 5
hematologi (5) 5
klinisk medicin (5) 5
young adult (5) 5
adherence (4) 4
blood coagulation factor viii (4) 4
factor ix - therapeutic use (4) 4
factor-ix (4) 4
health aspects (4) 4
hemarthrosis - prevention & control (4) 4
hemophilia a - pathology (4) 4
risk-factors (4) 4
tailoring (4) 4
age factors (3) 3
blood coagulation factors - therapeutic use (3) 3
clinical-trial (3) 3
developing countries (3) 3
dose-response relationship, drug (3) 3
evidence-based medicine (3) 3
factor viii - metabolism (3) 3
factor viii - pharmacokinetics (3) 3
female (3) 3
follow-up (3) 3
haemophilia b (3) 3
hemarthrosis - etiology (3) 3
hemophilia a - diagnosis (3) 3
hemophilia a - economics (3) 3
individualization (3) 3
joint health score (3) 3
management (3) 3
medication adherence (3) 3
mypkfit (3) 3
outcomes (3) 3
pediatrics (3) 3
phenotype (3) 3
previously untreated patients (3) 3
protocol (3) 3
review article (3) 3
risk factors (3) 3
severe hemophilia-a (3) 3
survival (3) 3
tailored therapy (3) 3
time factors (3) 3
treatment (3) 3
trial (3) 3
abr (2) 2
age (2) 2
analysis (2) 2
annual bleed rate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Expert Review of Hematology, ISSN 1747-4086, 04/2015, Volume 8, Issue 2, pp. 237 - 246
Prophylaxis is considered optimal care for patients with severe hemophilia to prevent bleeding, including hemarthroses, which may cause arthropathy with... 
pharmacokinetics | hemophilia | arthropathy | hemarthroses | prophylaxis | personalized medicine | ADULT PATIENTS | FC FUSION PROTEIN | RECOMBINANT FACTOR-VIII | TAILORED PROPHYLAXIS | PLASMA/ALBUMIN-FREE METHOD | SECONDARY PROPHYLAXIS | FACTOR-IX | ANIMAL-MODELS | QUALITY-OF-LIFE | PHARMACOKINETIC PROPERTIES | HEMATOLOGY
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 02/2012, Volume 38, Issue 1, pp. 79 - 94
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 10/2013, Volume 39, Issue 7, pp. 711 - 722
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 12/2016, Volume 9, Issue 12, pp. 1203 - 1208
Introduction: Prophylactic factor replacement is the standard of care for all people with severe hemophilia to prevent bleeding and associated complications.... 
pharmacokinetics | personalized prophylaxis | adherence | hemophilic arthropathy | Hemophilia | COST-EFFECTIVENESS | MYPKFIT | ARTHROPATHY | RECOMBINANT FACTOR-VIII | TAILORED PROPHYLAXIS | ON-DEMAND TREATMENT | HEALTH | HEMATOLOGY | JOINT | CLINICIAN PERSPECTIVE
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 07/2016, Volume 42, Issue 5, pp. 533 - 540
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 11/2017, Volume 10, Issue 11, pp. 995 - 1004
Introduction: Currently full dose prophylaxis is the standard of care in the treatment of hemophilia (World Federation of Hemophilia). However, the high costs... 
hemophilia | treatment | children | China | low dose prophylaxis | MULTICENTER | ARTHROPATHY | FACTOR-VIII | TAILORED PROPHYLAXIS | MODERATE HEMOPHILIA | SECONDARY PROPHYLAXIS | PHARMACOKINETICS | ON-DEMAND | HEALTH | HEMATOLOGY
Journal Article
HAMOSTASEOLOGIE, ISSN 0720-9355, 11/2013, Volume 33, Issue 4A, pp. S32 - S35
While prophylaxis with factor VIII (FVIII) is considered the first choice therapy for patients with severe haemophilia A the optimal prophylaxis regimen is... 
FVIII trough level | SEVERE HEMOPHILIA-A | ABR | Haemophilia A | annual bleed rate | ARTHROPATHY | SCORES | individualized treatment | target joint | PK tailored prophylaxis | HEMATOLOGY | CHILDREN
Journal Article
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 11/2015, Volume 41, Issue 8, pp. 864 - 871
Abstract Prophylactic replacement of factor concentrate is the established optimal treatment to avoid or minimize joint disease in severe hemophilia patients,... 
tailoring | hemophilia | individualization | prophylaxis | personalized | HALF-LIFE | CLINICAL-TRIAL | FC FUSION PROTEIN | RECOMBINANT FACTOR-VIII | TAILORED PROPHYLAXIS | PROPHYLACTIC TREATMENT | SECONDARY PROPHYLAXIS | PHARMACOKINETICS | ON-DEMAND | FACTOR-IX | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Hemophilia A - therapy | Humans
Journal Article
Expert Review of Pharmacoeconomics and Outcomes Research, ISSN 1473-7167, 05/2016, Volume 16, Issue 3, pp. 337 - 345
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.